Cargando…
Alzheimer’s disease: diagnostics, prognostics and the road to prevention
Alzheimer’s disease (AD) presents one of the leading healthcare challenges of the 21st century, with a projected worldwide prevalence of >107 million cases by 2025. While biomarkers have been identified, which may correlate with disease progression or subtype for the purpose of disease monitoring...
Autores principales: | Grossman, Iris, Lutz, Michael W., Crenshaw, Donna G., Saunders, Ann M., Burns, Daniel K., Roses, Allen D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987528/ https://www.ncbi.nlm.nih.gov/pubmed/21124753 http://dx.doi.org/10.1007/s13167-010-0024-3 |
Ejemplares similares
-
Characterization of the Poly-T Variant in the TOMM40 Gene in Diverse Populations
por: Linnertz, Colton, et al.
Publicado: (2012) -
A genetics-based biomarker risk algorithm for predicting risk of Alzheimer's disease
por: Lutz, Michael W., et al.
Publicado: (2016) -
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
por: Roses, A D, et al.
Publicado: (2010) -
APOE ε4-TOMM40 ‘523 haplotypes and the risk of Alzheimer’s disease in older Caucasian and African Americans
por: Yu, Lei, et al.
Publicado: (2017) -
Effects of Low Doses of Pioglitazone on Resting-State Functional Connectivity in Conscious Rat Brain
por: Crenshaw, Donna G., et al.
Publicado: (2015)